Abiomed, Inc. (NASDAQ: ABMD) reports a Q4 loss of $0.22, 3 cents better than estimates. Revenues were $13.9 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE